These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 18488391)
41. Agreement of time-domain and spectral-domain optical coherence tomography with fluorescein leakage from choroidal neovascularization. Khurana RN; Dupas B; Bressler NM Ophthalmology; 2010 Jul; 117(7):1376-80. PubMed ID: 20452027 [TBL] [Abstract][Full Text] [Related]
42. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A Retina; 2006; 26(9):999-1005. PubMed ID: 17151486 [TBL] [Abstract][Full Text] [Related]
43. Age-related macular degeneration and risk factors for the development of choroidal neovascularisation in the fellow eye: a 3-year follow-up study. Silva R; Cachulo ML; Fonseca P; Bernardes R; Nunes S; Vilhena N; Faria de Abreu JR Ophthalmologica; 2011; 226(3):110-8. PubMed ID: 21822000 [TBL] [Abstract][Full Text] [Related]
48. Use of optical coherence tomography, fluorescein angiography and indocyanine green angiography in a screening clinic for wet age-related macular degeneration. Talks J; Koshy Z; Chatzinikolas K Br J Ophthalmol; 2007 May; 91(5):600-1. PubMed ID: 17151058 [TBL] [Abstract][Full Text] [Related]
49. Correlation of visual function impairment and optical coherence tomography findings in patients with adult-onset foveomacular vitelliform macular dystrophy. Querques G; Bux AV; Prato R; Iaculli C; Souied EH; Delle Noci N Am J Ophthalmol; 2008 Jul; 146(1):135-142. PubMed ID: 18439561 [TBL] [Abstract][Full Text] [Related]
50. Optical coherence tomography in diagnosing, differentiating and monitoring of choroidal nevi - 1 year observational study. Golebiewska J; Kecik D; Turczynska M; Ciszewska J; Moneta-Wielgos J; Pihowicz-Bakon K Neuro Endocrinol Lett; 2013; 34(6):539-42. PubMed ID: 24378457 [TBL] [Abstract][Full Text] [Related]
51. Vitelliform dystrophies: Prevalence in Olmsted County, Minnesota, United States. Dalvin LA; Pulido JS; Marmorstein AD Ophthalmic Genet; 2017; 38(2):143-147. PubMed ID: 27120116 [TBL] [Abstract][Full Text] [Related]
52. Optical coherence tomographic assessment of diabetic macular edema: comparison with fluorescein angiographic and clinical findings. Ozdek SC; Erdinç MA; Gürelik G; Aydin B; Bahçeci U; Hasanreisoğlu B Ophthalmologica; 2005; 219(2):86-92. PubMed ID: 15802932 [TBL] [Abstract][Full Text] [Related]
53. Clinical characteristics and visual function tests with retinal tomographic correlation in patients with Stargardt's disease in Taiwan. Sun JP; Chen MS; Jou JR; Lin CP; Tsai TH; Ho TC J Formos Med Assoc; 2013 Feb; 112(2):79-86. PubMed ID: 23380609 [TBL] [Abstract][Full Text] [Related]
54. Optical Coherence Tomography Angiography in Retinal Vein Occlusion: Evaluation of Superficial and Deep Capillary Plexa. Coscas F; Glacet-Bernard A; Miere A; Caillaux V; Uzzan J; Lupidi M; Coscas G; Souied EH Am J Ophthalmol; 2016 Jan; 161():160-71.e1-2. PubMed ID: 26476211 [TBL] [Abstract][Full Text] [Related]
55. Fundus autofluorescence patterns in Best vitelliform macular dystrophy. Parodi MB; Iacono P; Campa C; Del Turco C; Bandello F Am J Ophthalmol; 2014 Nov; 158(5):1086-92. PubMed ID: 25068640 [TBL] [Abstract][Full Text] [Related]
57. Assessment of central visual function in Stargardt's disease/fundus flavimaculatus with ultrahigh-resolution optical coherence tomography. Ergun E; Hermann B; Wirtitsch M; Unterhuber A; Ko TH; Sattmann H; Scholda C; Fujimoto JG; Stur M; Drexler W Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):310-6. PubMed ID: 15623790 [TBL] [Abstract][Full Text] [Related]
58. Correlation of high-definition optical coherence tomography and fluorescein angiography imaging in neovascular macular degeneration. Malamos P; Sacu S; Georgopoulos M; Kiss C; Pruente C; Schmidt-Erfurth U Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4926-33. PubMed ID: 19494200 [TBL] [Abstract][Full Text] [Related]
59. Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age-related macular degeneration. Krämer F; White K; Pauleikhoff D; Gehrig A; Passmore L; Rivera A; Rudolph G; Kellner U; Andrassi M; Lorenz B; Rohrschneider K; Blankenagel A; Jurklies B; Schilling H; Schütt F; Holz FG; Weber BH Eur J Hum Genet; 2000 Apr; 8(4):286-92. PubMed ID: 10854112 [TBL] [Abstract][Full Text] [Related]
60. [Application of optical coherent tomography in monitoring age-related macular degeneration after photodynamic therapy]. Piłat J; Wylegała E Klin Oczna; 2009; 111(7-9):229-34. PubMed ID: 19899580 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]